In T lymphocytes, sustained calcium (Ca 2؉ ) influx through Ca 2؉ channels localized in the plasma membrane is critical for T cell activation and proliferation. Previous studies indicated that voltage-dependent Ca 2؉ channels (VDCCs) play a role in Ca 2؉ mobilization during T lymphocyte activation. However, the role of VDCCs in otherwise nonexcitable cells is still poorly understood. We used RT-PCR to identify a transcript encoding the pore-forming ␣ 1F -subunit of an L-type Ca 2؉ channel in T lymphocytes. Its identity was confirmed by DNA sequencing. To further investigate the contribution of Ca 2؉ influx through VDCCs, we assessed the effects of the 1,4-dihydropyridine L-type Ca 2؉ channel agonist, (؉/؊) Bay K 8644, and antagonist, nifedipine, on the human Jurkat T cell leukemia line, human peripheral blood T lymphocytes and mouse splenocytes. We found that treatment of T lymphocytes with (؉/؊) Bay K 8644 increased intracellular Ca 2؉ and induced the activation of phosphoextracellular-regulated kinase 1/2 (Erk1/2), whereas nifedipine blocked Ca 2؉ influx, the activity of Erk1/2 and nuclear factor of activated T cells (NFAT), interleukin-2 (IL-2) production, and IL-2 receptor expression. Nifedipine also significantly suppressed splenocyte proliferation in an in vitro mixed lymphocyte reaction and the proliferation of male antigen (H-Y)-specific T cell receptor-transgenic CD8 ؉ T cells in transplanted male mice in vivo. Taken together these novel findings indicate that an L-type Ca 2؉ channel plays a significant role in the Ca 2؉ influx pathways mediating T lymphocyte activation and proliferation in vitro and in vivo.